Detalhe da pesquisa
1.
Long-term persistence of immune response to the AS04-adjuvanted HPV-16/18 vaccine in Chinese girls aged 9-17 years: Results from an 8-9-year follow-up phase III open-label study.
Asia Pac J Clin Oncol
; 16(6): 392-399, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32780946